Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Charles

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Disease Markers|March 1, 1991
HLA-B40: a marker for susceptibility to lung disease in rheumatoid arthritisP J Charles, M C Sweatman, J R Markwick, et al.
Rheumatology International|January 1, 1993
Serological profile of rheumatoid arthritis in west AfricaA O Adebajo, P J Charles, B L Hazleman, et al.
Rheumatology International|January 1, 1986
Antibody class differences are detected in anti-nRNP and anti-Sm antibodies directed against distinct antigen subunitsD G Williams, M R Stocks, P J Charles, et al.
Journal of Immunological Methods|July 11, 1986
Antibodies to La, Jo-1, nRNP and Sm detected by multi-track immunoblotting using a novel filter holder: a comparative study with counterimmunoelectrophoresis and immunodiffusion using sera from patients with systemic lupus erythematosus and Sjögren's syndromeD G Williams, M R Stocks, P J Charles, et al.
British Journal of Rheumatology|October 1, 1993
Antineutrophil cytoplasmic antibody titres in patients with recent infectionA O Adebajo, P J Charles, B L Hazleman, et al.
British Journal of Rheumatology|May 1, 1995
Sulphasalazine-induced autoimmune abnormalities in patients with rheumatic diseaseC J Laversuch, D A Collins, P J Charles, et al.
British Journal of Rheumatology|July 1, 1993
Serological and immunogenetic markers of extraglandular primary Sjögren's syndromeC T Pease, P J Charles, W Shattles, et al.
Arthritis and Rheumatism|November 18, 2000
Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trialsP J Charles, R J Smeenk, J De Jong, et al.
Clinical Rheumatology|March 1, 1990
Antinuclear antibody determination methodsD G Williams, P J Charles, M Field, et al.
Clinical and Experimental Rheumatology|March 1, 1989
Clinical, serological, and HLA phenotype subsets in Sjögren's syndromeC T Pease, W Shattles, P J Charles, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Disease Markers|March 1, 1991
HLA-B40: a marker for susceptibility to lung disease in rheumatoid arthritisP J Charles, M C Sweatman, J R Markwick, et al.
Rheumatology International|January 1, 1993
Serological profile of rheumatoid arthritis in west AfricaA O Adebajo, P J Charles, B L Hazleman, et al.
Rheumatology International|January 1, 1986
Antibody class differences are detected in anti-nRNP and anti-Sm antibodies directed against distinct antigen subunitsD G Williams, M R Stocks, P J Charles, et al.
Journal of Immunological Methods|July 11, 1986
Antibodies to La, Jo-1, nRNP and Sm detected by multi-track immunoblotting using a novel filter holder: a comparative study with counterimmunoelectrophoresis and immunodiffusion using sera from patients with systemic lupus erythematosus and Sjögren's syndromeD G Williams, M R Stocks, P J Charles, et al.
British Journal of Rheumatology|October 1, 1993
Antineutrophil cytoplasmic antibody titres in patients with recent infectionA O Adebajo, P J Charles, B L Hazleman, et al.
British Journal of Rheumatology|May 1, 1995
Sulphasalazine-induced autoimmune abnormalities in patients with rheumatic diseaseC J Laversuch, D A Collins, P J Charles, et al.
British Journal of Rheumatology|July 1, 1993
Serological and immunogenetic markers of extraglandular primary Sjögren's syndromeC T Pease, P J Charles, W Shattles, et al.
Arthritis and Rheumatism|November 18, 2000
Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trialsP J Charles, R J Smeenk, J De Jong, et al.
Clinical Rheumatology|March 1, 1990
Antinuclear antibody determination methodsD G Williams, P J Charles, M Field, et al.
Clinical and Experimental Rheumatology|March 1, 1989
Clinical, serological, and HLA phenotype subsets in Sjögren's syndromeC T Pease, W Shattles, P J Charles, et al.
Pageof 4